The global IBS-C drug market is expected to grow at a CAGR of 6.30% during the forecast period of 2017 – 2025. Some of the primary factors responsible for the growth in the market are the ease of availability of effective drugs in the market, modern dietary habits affecting the health, various psychological factors affecting the irritable bowel syndrome and the opportunity of improved and efficient drugs in the pipeline with many first-in-class molecules